MEDICO REMEDIES LIMITED
MEDICO · General/Diversified · NSE
₹43
Current Market Price
Fair Value (DCF)
₹16
Discount to FV
-62.2%
Updated just now
YieldIQ Score
40/100
Piotroski F-Score
5/9
Economic Moat
Moderate
Confidence
41%
ROE
17.4%
Debt/Equity
0.25
WACC
11.1%
Market Cap
₹359.65 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
24.3%
Return on capital employed
EV / EBITDA
24.0×
Enterprise multiple
Debt / EBITDA
1.1×
Leverage vs earnings
Interest Coverage
16.9×
EBIT covers interest
Current Ratio
1.70×
Short-term liquidity
Asset Turnover
1.72×
Revenue per ₹ of assets
Revenue CAGR (3Y)
14.2%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹43.34
Bear case
Margin of Safety —
Implied upside -353.3%
Base case
Margin of Safety —
Implied upside -164.4%
Bull case
Margin of Safety —
Implied upside -110.0%
Ratio Trends
MEDICO · last 5 annual periods
ROE
17.4%
ROCE
24.3%
Operating Margin
—
Debt / Equity
0.25×
PE
86.0×
EV / EBITDA
39.2×
Historical Financials
MEDICO · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹118 Cr | ₹138 Cr | ₹143 Cr | ₹151 Cr | ₹206 Cr | +14.9% |
| EBITDA | ₹11.4 Cr | ₹16.1 Cr | ₹14.9 Cr | ₹17.7 Cr | ₹23.0 Cr | +19.1% |
| EBIT | — | ₹10.8 Cr | ₹12.2 Cr | — | — | +2.9% |
| PAT | ₹4.8 Cr | ₹7.2 Cr | ₹8.3 Cr | ₹10.1 Cr | ₹13.1 Cr | +28.5% |
| EPS (diluted) | — | ₹0.87 | ₹1.00 | — | — | +3.5% |
| CFO | ₹5.9 Cr | ₹8.2 Cr | ₹2.4 Cr | ₹4.9 Cr | ₹5.9 Cr | +0.1% |
| CapEx | ₹-5.9 Cr | ₹-6.6 Cr | ₹-2.5 Cr | ₹-3.2 Cr | ₹-4.5 Cr | — |
| FCF | ₹-0.1 Cr | ₹1.6 Cr | ₹-0.0 Cr | ₹1.7 Cr | ₹1.4 Cr | — |
| Total Assets | ₹77.4 Cr | ₹87.4 Cr | ₹96.2 Cr | ₹120 Cr | ₹153 Cr | +18.6% |
| Total Debt | ₹12.6 Cr | ₹9.8 Cr | ₹8.1 Cr | ₹14.7 Cr | ₹19.2 Cr | +11.1% |
| Shareholders' Equity | ₹36.6 Cr | ₹43.8 Cr | ₹52.4 Cr | ₹62.5 Cr | ₹75.5 Cr | +19.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MEDICO vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
BAFNAPH BAFNAPH | — | — | Pending | 11.5% | — |
MEDICAMEQ MEDICAMEQ | — | — | Pending | 3.4% | — |
VALIANTLAB VALIANTLAB | — | — | Pending | -0.9% | — |
ALBERTDAVD ALBERTDAVD | — | — | Pending | -0.4% | — |
ZIMLAB ZIMLAB | — | — | Pending | 4.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for MEDICO in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. MEDICO REMEDIES LIMITED (MEDICO.NS) trades at 43.34 vs a model fair value of 16.39, a gap of -62.2%. Piotroski F-score: 5/9. Moat label: ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MEDICO →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MEDICO →
Compare
Head-to-head with peers
Compare MEDICO side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MEDICONow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.